최영진 교수 연구실
article|
gold
·인용수 1
·2023
An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer
Anbok Lee, Taewoo Kang, Su Hwan Kang, Woo Chan Park, Woosung Lim, Myung-Chul Chang, Hyun Yul Kim, Jeong-Yoon Song, Jihyoun Lee, Kyung Do Byun, Hyun‐Ah Kim, Gil Soo Son, Ju‐Yeon Kim, Se Jeong Oh, Min Sung Chung, Young Jin Choi, Hyukjai Shin, Jong Min Baek, Young-Bum Yoo, Eunhae Um, Jin‐Hyuk Choi, Beom Seok Kwak, Min Ho Park, Suok Hyun Lee, Cheol Seung Kim, Ilkyun Lee, Je Ryong Kim, Han Shin Lee, Cheol Wan Lim
IF 7.9The Breast
초록
The use of pegfilgrastim as secondary prophylaxis was effective and safe for preventing FN in patients with breast cancer who were treated with chemotherapy.
키워드
PegfilgrastimMedicineFebrile neutropeniaInternal medicineClinical endpointBreast cancerNeutropeniaBone painIncidence (geometry)Adverse effect